European Society of Toxicology In Vitro > Uncategorized > ESTIV/ASCCT Announcement on SOT: Qureator Hands-On Event March 22, 2026
20 February 2026

ESTIV/ASCCT Announcement on SOT: Qureator Hands-On Event March 22, 2026

Are you attending SOT? Will you be in San Diego on March 22?

The Physicians Committee for Responsible Medicine and Qureator are hosting a FREE in-person workshop and lab tour on March 22 ahead of the SOT kickoff. Qureator is a biotechnology company recently shortlisted for the Lush Science Prize. They are transforming the drug discovery process with their vascularized organoid technology that has been used to secure FDA IND approval without animal proof-of-concept data.


Date: March 22, 2026
Time: 9:30 am – 12:00 pm ET / 14:30 – 17:00 UTC

In this workshop, participants will gain first-hand experience with next-generation preclinical validation using Qureator’s human-derived vascularized organoids, tour the facility, and hear from scientists working with the models and leaders working to advance human-specific non-animal approaches. Transportation to and from the San Diego Convention Center (SOT venue) and lunch will be provided. 

REGISTER NOW

This event is limited to 20 participants, and registration is required.

Complete details are also available on the Event Calendar Listing.
Recordings and other materials from this webinar will be posted to the ASCCT Webinar Archive.
Information on additional upcoming webinars and other events is available on the ASCCT Event Calendar.

Related content

The ESTIV 2026 Special Issue is open for submissions

Toxicology in Vitro is now accepting manuscripts for the Special Issue arising from the ESTIV 2026 Congress held in Maastricht. The collection takes its direction from the congress theme — “Ensuring Safety, Advancing Science: Bridging to the Future with NAMs” — and is open until 31 December 2026.

ESTIV: ERA4NAMs Survey – request for contribution

The ERA4NAMs Working Group on Education and Training is conducting a mapping exercise to identify existing training activities, educational resources, and capacity-building initiatives related to New Approach Methodologies (NAMs) across Europe and beyond.

The inaugural Liebsch & Spielmann Award presented at the ESTIV 2026 Congress

The European Society of Toxicology In Vitro (ESTIV) is proud to announce the recipients of the inaugural Liebsch & Spielmann Award for Contributions to the Validation of Alternative Methods.

Silver Sponsor

Communication partners

Memorandum of Understanding